Try GOLD - Free
SEBI's PARRVA Scheme: Will It Build Trust in Investment Performance Claims?
Mint Kolkata
|April 16, 2025
In a move to enhance transparency and accountability in India's securities market, the Securities and Exchange Board of India (Sebi) issued a circular on 4 April, outlining a regulatory framework for Past Performance and Risk-Return Verification Agency (PARRVA).
The framework introduces a system to verify performance claims made by investment advisors, research analysts, and algo providers (collectively, regulated persons).
A registered credit rating agency will be designated as PARRVA, tasked with verifying risk-return metrics of investment advice, strategies, and model portfolios before they are promoted or displayed. PARRVA will work with a recognized stock exchange to set up the PARRVA Data Centre (PDC), which will act as its data collection and dissemination hub.
The PDC, in partnership with other Market Infrastructure Institutions (MIIs), AMFI (for mutual fund NAVs), and Regulated Persons, will gather raw data. It will use this data to generate verified outputs based on a methodology set by PARRVA. These verified data sets will be published on PARRVA's website with detailed disclosures and disclaimers.
The framework aims to prevent selective or misleading performance displays. Regulated Persons can no longer highlight a single successful stock pick, model portfolio, or algorithm. They must present the full set of recommendations or strategies submitted for verification, along with disclosures, risk caveats, and QR codes linking to PARRVA for complete performance details.
This story is from the April 16, 2025 edition of Mint Kolkata.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Kolkata
Mint Kolkata
When LLMs learn to take shortcuts, they become evil
Some helpful parenting tips: it is very easy to accidentally teach your children lessons you did not intend to pass on.
2 mins
November 28, 2025
Mint Kolkata
Investors expect AI use to soar. That's not happening
An uncertain outlook for interest rates. Businesses may be holding off on investment until the fog clears. In addition, history suggests that technology tends to spread in fits and starts. Consider use of the computer within American households, where the speed of adoption slowed in the late 1980s. This was a mere blip before the 1990s, when they invaded American homes.
2 mins
November 28, 2025
Mint Kolkata
Would you like to be interviewed by an AI bot instead?
don't think I want to be interviewed by a human again,\" said a 58-year-old chartered accountant who recently had an interview with a multinational company.
3 mins
November 28, 2025
Mint Kolkata
Can I claim TDS refund despite missing return filing deadline?
I am an NRI living in Dubai and have investments in Indian listed stocks. One of the companies I invested in, did a buyback in March, on which Tax Deducted at Source (TDS) was deducted. At that time, I was advised by a friend that I could claim a refund of TDS at the time of filing my tax return due to the benefits of the Double Taxation Avoidance Agreement (DTAA).
2 mins
November 28, 2025
Mint Kolkata
Tech startups on M&A route to boost scale, market share
M&As were earlier used to enter new markets or geographies, but that strategy has evolved
2 mins
November 28, 2025
Mint Kolkata
Doing India’s needy a good turn: Everyone is welcome to pitch in
What may seem weakly linked with positive outcomes on the ground could work wonders over time
3 mins
November 28, 2025
Mint Kolkata
Refiners, SCI tap Korean giants for local shipyard
Indian Oil, Bharat Petroleum and Hindustan Petroleum are part of the discussions
2 mins
November 28, 2025
Mint Kolkata
It's a multi-horse Street race now as Smids muscle in
For years, India’s stock market ran on the shoulders of a few giants. Not anymore.
1 mins
November 28, 2025
Mint Kolkata
Catamaran to boost manufacturing bets
Catamaran is focused on a few areas in manufacturing, such as aerospace
2 mins
November 28, 2025
Mint Kolkata
What if China weaponizes its dominance of pharma inputs?
Overdependence on China for drug-making should worry the US
3 mins
November 28, 2025
Listen
Translate
Change font size

